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Objectives. To investigate the impact of patient characteristics and treatmentmodality (graft thrombectomyvs thrombolysis)
on the results of redo procedures for occluded above-knee prosthetic femoropopliteal grafts implanted for critical ischaemia.
Material and methods. Fifty-five procedures (thrombolysis 24 and thrombectomy 31) were performed on 24 prostheses
(23 patients, 24 limbs) between January 1990 and December 2001. All cases were prospectively registered. Graft patency,
limb salvage and survival rates were studied and subgroups of patients were compared. Risk factors were analysed with the
use of log rank test and Cox proportional hazard analysis.
Results. Half of the 24 initial procedures to restored patency failed within one month. The outcome of second- or third-time
redo procedures was similiar. The primary patency rates of all 55 redo procedures were 32% at three months, 28% at six
months and 12% at 12 months. The results of thrombectomy and thrombolysis were similar. Re-opened grafts additionally
treated for an underlying anastomotic stenosis had significantly better patency as compared with re-opened grafts without
a pre-existing stenosis on both univariate analysis (p¼ 0.024) and multivariate analysis (p¼ 0.027, hazard ratio 2.813).
The one-year limb salvage rate was 76%. The one- and five-year survival rates were 87% and 52%, respectively.
Conclusions. The results of redo procedures for occluded above-knee prosthetic grafts were disappointing. Grafts in which
a graft-related stenosis was treated performed better than grafts in which occlusion could not be attributed to an underlying
stenosis. Such cases should most likely be offered conservative treatment, amputation or a new arterial reconstruction.
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The management of occluded prosthetic grafts is
complex and represents a challenge for the vascular
surgeon. The risk of amputation after a failed
above-knee prosthetic bypass is high.1 Occluded
femoropopliteal prosthetic grafts may be re-opened
either by graft thrombectomy or thrombolysis. Cases
with an underlying inflow, outflow or anastomotic
stenosis may be treated with patch angioplasty
(open surgery) or percutaneous transluminal angio-
plasty (PTA) to eliminate the stenosis. Other treatment
options in these patients are conservative, a new
arterial reconstruction or amputation.
The aim of this study was to investigate the impact
of patient characteristics and treatment modality (graft
thrombectomy or thrombolysis) on the results of
redo procedures for occluded above-knee prosthetic
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Patients and Methods
One-hundred-and-eleven above-knee prosthetic fem-
oropopliteal bypass operations for critical ischaemia
were performed between Jan 1990 and Dec 2001.
The operations were prospectively recorded into a
vascular registry, run by the department. The results
of these operations have previously been reported.2
Fifty-three grafts occluded during follow-up of which
24 were subjected to a total of 55 redo procedures (24
thrombolysis and 31 thrombectomy). These redo pro-
cedures constitute the material of the present study.
Twenty-nine cases were recorded with primary graft
occlusion without being re-opened and the outcome
of these was also studied.
The total number of femoropoplital bypasses per-
formed in Haukeland University Hospital in the
same time period were 388, of which 279 wereserved.
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above-knee femoropoplital bypass, a vein was used
as conduit in 27 cases whereas a prosthesis was
used in 252 cases. Above-knee prosthetic bypass was
performed for intermittent claudication in 141 cases
and for critical ischaemia in 111 cases. For below-
knee femoropopliteal bypass, an autologous vein
was used in 75 cases, human umbilical vein in two
cases, a composite graft in 13 cases and a prosthetic
graft in 19 cases.
Patient characteristics
The mean and median age of the patients was 71 and
70 years (range 53e87). There were seven women and
16 men. The recorded preoperative patient character-
istics are illustrated in Table 1. The indication for the
primary operation was critical ischemia in all cases.
Critical ischemia was defined according to the second
European Consensus Document on chronic critical leg
iscaemia.3 Poor run-off score was defined as one pat-
ent crural artery or less, as seen on the preoperative
angiogram. Poor run-off was recorded in 10 limbs
(42%). In one case, graft implantation was performed
without a preoperative angiography. Selection criteria
for the treatment chosen were not clearly defined, but
patients unfit for thrombolysis according to the rec-
ommendations of the Working Party on Thrombolysis
in the Management of Limb Ischaemia were selected
for thrombectomy.3 Three cases of failed thrombolysis
were subsequently subjected to open surgery.
Thrombolysis
The endovascular procedures (n¼ 24) were per-
formed with a crossover technique. The catheter was
placed in the thrombus with constant release of
thrombolytic agent. The catheter was re-positioned
more distally as the thrombus dissolved. Until April
1997 Streptokinase (40 000 IE/hour) was used as
thrombolytic agent. Recombinant human tissue-type
plasminogen activator (rt-PA) was used in all later
Table 1. Patient characteristics in 23 patients with re-opened grafts
originally implanted for critical ischaemia. (COPD[ chronic
obstructive pulmonary disease)
Risk factor n¼ cases
Hypertension 9/21
Diabetes mellitus 3/21
COPD 7/21
Coronary disease 9/23
Cerebrovascular insult 3/23
s-Creatinin >125 mmol/l 4/22
Smoking 17/20procedures. A bolus dose of 5 mg was injected into
the thrombus, followed by a continuous infusion
(1.5 mg/hour). Cases complicated with distal emboli-
zation were managed with further thrombolysis or
endovascular aspiration. Percutaneous transluminal
angioplasty (PTA) after thrombolysis was successfully
performed in six cases. In 18 cases, anastomotic steno-
ses were not found at completion angiography.
Thrombectomy
The open operations (n¼ 31) were done with an inci-
sion over the distal anastomosis. The graft was incised
and the anastomotic area was assessed intraluminally
after thrombectomy. The thrombectomy was per-
formed with a graft thrombectomy catheter. Anasto-
motic revision was performed in four cases. No
evidence of graft stenosis had been identified during
duplex surveillance of these 4 grafts. In the remaining
27 cases, freedom of stenosis was diagnosed with
angiography in 20 cases and with duplex scanning
in four cases. In three cases the only information re-
garding the anastomoses was that the balloon catheter
passed the anastomoses without difficulty.
Follow-up
Postoperatively, all patients were given aspirin
160 mg daily on a permanent basis if tolerated.
Follow-up included duplex scanning, ankle-brachial
pressure measurement and clinical assessment at
one, three, six and 12 months after surgery and annu-
ally thereafter. New procedures entered a new proto-
col for follow-up. The endpoints in this study were
occlusion, major amputation and death. Graft occlu-
sion was diagnosed by duplex scanning or by angio-
graphic findings. The mean follow-up with respect
to patency after re-opening procedures was 4 months
(range 0e36 months). The mean follow-up with re-
spect to limb salvage was 31 months (range 0e88
months) whereas the mean follow-up regarding sur-
vival was 59 months (0e137 months). Mortality data
were obtained from The Registrars Office of Birth
and Death.
Statistics
Patency, limb salvage and survival analyses were
done using the product-limit method and illustrated
as Kaplan-Meier curves. Calculations of patency
were performed on an intention-to-treat basis. Univar-
iate analysis of patency was performed with the log
rank test whereas the Cox proportional hazard modelEur J Vasc Endovasc Surg Vol 32, December 2006
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risk factors. Calculations of limb salvage and survival
analysis were based upon the date of the first redo
procedure. Comparisons of patency between groups
were performed with log rank test. Categorical data
were analysed with Fisher’s exact test. The software
program ‘‘SPSS for Windows 13.0’’ (SPSS Inc. (2004),
Illinois, USA) was used for statistical computations.
Differences were considered statistically significant
at the 5% level ( p< 0.05).
Results
Re-opening procedures
Twenty-four first-time redo procedures (graft throm-
bectomy 13 and thrombolysis 11) were performed.
The mean and median time intervals from the pri-
mary graft implantation to the first redo procedure
were 18 and 9 months (range 0e84). In Table 2, the
grafts are categorised according to the number of re-
opening procedures. Fifty-three of 55 redo procedures
re-occluded during follow-up, leaving out one patient
who died after thrombolysis and one patient lost to
follow-up. There were no differences between first,
second and third-time redo procedures with respect
to patency. Twenty-nine re-occlusions (53%) occurred
within one month after the re-opening procedure. The
patency rates for all redo procedures were 32% at
three months, 28% at six months and 12% at 12
months (Fig. 1). Graft thrombectomy and thromboly-
sis had similar patency rates ( p¼ 0.90, log rank test)
as did thrombolysis with streptokinase compared to
rt-PA. None of the recorded patient characteristics
influenced patency of the redo procedures.
Anastomotic revisions
Revision was done in 10 cases (six thrombolyses by
PTA, four thrombectomies by patch angioplasty).
Three of these grafts occluded within one month
postoperatively. Three grafts were patent for 17, 34
and 36 months respectively and these were in the
thrombectomy group. One case had no record of
Table 2. Grafts categorised according to how many times they
were re-opened
Procedure 1 Re-opening
(n¼ 24)
2 Re-opening
(n¼ 16)
3 or >Re-openings
(n¼ 15)
Graft
thrombectomy
(n¼ 31)
n¼ 13 n¼ 10 n¼ 8
Thrombolysis
(n¼ 24)
n¼ 11 n¼ 6 n¼ 7Eur J Vasc Endovasc Surg Vol 32, December 2006follow-up. At 12 months postoperatively, four out of
10 patients receiving redo procedures including anas-
tomotic revision were alive with patent graft. Uni-
variate analysis revealed anastomotic revision to be
associated with improved patency ( p¼ 0.024, log
rank test) (Fig. 2). This association was also confirmed
on multivariate analysis ( p¼ 0.027, Cox regression
analysis) with a hazard ratio of 2.813 (Table 3).
0 3 6 9 12
Months
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1,0
P
r
i
m
a
r
y
 
p
a
t
e
n
c
y
19
17
12
9
Fig. 1. Kaplan-Meier curve: The patency rates of 55 re-
opening procedures for occluded prosthetic above-knee
femoropopliteal bypass. The numbers above the curve
indicate the numbers at risk.
15129630
Months
1,0
0,8
0,6
0,4
0,2
0,0
P
r
i
m
a
r
y
 
p
a
t
e
n
c
y
3
7
13
1
7
6
5
4
Fig. 2. Kaplan-Meier curve: The patency rates of 45 redo
procedures for graft occlusions without a graft-related ste-
nosis (lower curve) compared with 10 re-opening proce-
dures in which also an anastomotic revision was done
(upper curve). The numbers above and below the curves in-
dicate the numbers at risk.
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Thirteen limbs in 13 patients (57%) were subjected to
major amputation. The limb salvage rates were 76%
and 64% at one and two years respectively after
re-opening procedures. None of the recorded patient
characteristics influenced limb salvage. Twenty-nine
cases with occluded grafts were not subjected to
redo procedures, of which 14 limbs were amputated.
Survival
One patient died two days postoperatively due to ce-
rebral haemorrhage as a complication of thromboly-
sis. At 12 months, 20 of 23 patients were still alive
(87%). The five-year survival rate was 52%. None of
the recorded patient characteristics were significantly
associated with reduced survival.
New arterial reconstruction
Four patients received a new bypass. In one case
a femoropopliteal vein graft was placed. This graft
remained patent throughout follow-up. Three limbs
were treated with a femorodistal vein bypasses of
which all occluded and the patients subsequently
required amputation.
Discussion
The choice of treatment modality may be difficult
when a patient presents with critical ischemia due
to an occluded above-knee femoropopliteal graft.
The treatment options are conservative, amputation,
re-opening of the occluded graft or a new arterial
reconstruction. The latter may be performed with
subintimal angioplasty or a new bypass. Patients
who originally receive a prosthetic graft for critical
Table 3. Cox regression analysis of risk factors for reduced
patency in 55 redo procedures for occluded above-knee femoro-
popliteal prostheses implanted for critical ischaemia
Risk factor p-value Hazard ratio 95% CI1
No presence
of graft-related stenosis
0.027 2.813 1.125e7.038
Thrombectomy vs
thrombolysis
0.127 1.594 0.875e2.902
Poor run-off score2 0.342 1.329 0.739e2.392
Tissue loss
vs rest pain
0.584 0.841 0.453e1.561
1 CI: Confidence Interval.
2 Poor run-off score was defined as one patent crural artery or less
as seen on the preoperative angiogram.ischemia are likely to develop recurrent critical
ischemia in case of graft occlusion. This often
demands intervention to avoid a major amputation
or to relieve pain. There are reports of acceptable
results of re-opening procedures for occluded
above-knee femoropopliteal prostheses.4,5 However,
these studies include cases with intermittent claudi-
cation as well as critical ischaemia. In a study by
AbuRahma et al., limbs with less than two open tibial
arteries were excluded, as were patients with inflow
disease.4 The indication for all graft implantations in
the present study was critical ischemia and none
were excluded.
The results of the present series are not encourag-
ing. A previous paper reported a three-year patency
of redo procedures of 12e20%.6 Our department has
previously reported a 12-month patency of 29% after
redo operations for occluded above-knee prosthetic
femoropopliteal bypass implanted for intermittent
claudication.7
Re-opened grafts commonly re-thrombose. This
was especially true for grafts that occluded without
an underlying stenotic lesion, which was the case in
45 procedures. These grafts may have occluded
because of low blood flow, possibly due to progres-
sion of distal atherosclerotic disease leading to high
peripheral resistance. Low graft flow could also be
due to inactivity or smoking (85% of the patients in
the present series were smokers). According to a
recently published meta-analysis, smokers have
a three-fold risk of graft failure compared with non-
smokers.8 This could not be verified for the redo pro-
cedures in the present study, probably due to the
overall very low patency rates and small sample
size. In an earlier study, we found that smoking was
significantly associated with reduced primary and
secondary patency of the primary bypass operations.2
Primary occlusion of above-knee femoropopliteal
prostheses occurring within 10 months has been as-
sociated with poor results of re-opening proce-
dures.5,9 The length of time before graft occlusion
after primary implantation did not influence the re-
sults after re-opening in the present series. Surgical
redo preocedures have been reported superior to
the results of endovascular treatment.4 However,
that conclusion was based only on patients treated
for an additional stenotic lesion. Our results revealed
no difference between the results of thrombolysis
and graft thrombectomy. Redo procedures that
included treatment of a stenotic anastomotic lesion
resulted in prolonged patency in three cases. This
may indicate that some patients may benefit from
a redo procedure if a stenotic lesion is known prior
to graft occlusion, which is in agreement withEur J Vasc Endovasc Surg Vol 32, December 2006
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motic stenosis prior to graft occlusion may be impor-
tant. This again may indicate a benefit of graft
surveillance. However, the numbers in the present
study are too small for conclusion in this respect.
Obviously, the optimal treatment is PTA of a graft-
related stenosis to prevent occlusion. A liberal policy
regarding treatment of graft-related stenoses may be
beneficial, but we have no data to support this.
Both hypertension and poor run-off has been asso-
ciated with reduced patency of redo procedures for
occluded grafts.11e13 Neither comorbidity nor poor
run-off were associated with reduced patency in the
present study, probably due to small sample size.
Thirteen limbs were subjected to major amputation,
giving a one-year limb salvage rate of 76%. This is
consistent with results from a previous study.14
Whether the repeated redo procedures influenced
limb salvage or not remains unknown; 16 of 24 grafts
were re-opened twice or more.
In the present series, ten limbs had poor run-off
score in whom a femoropopliteal bypass may have
been insufficient to treat critical ischaemia, as these
patients most likely had multi-level disease.15 Femo-
rodistal bypass might have been more suitable for
some of those patients. In the present series, femoro-
distal bypass was used as a last resort and the results
of these procedures were poor.
The high prevalence of cardiac disease and other
comorbidity illustrates that patients with critical is-
chemia are at high-risk following surgery and inva-
sive procedures (Table 1). In the present series, one
patient died within 30 days due to cerebral haemor-
rhage, underlining thrombolysis as a dangerous
treatment.16
Even if a re-opened graft is patent only for a limited
period of time, the patient may benefit from a pain-
free interval and sustained ability to walk. Some
patients may find such a result acceptable. However,
one could claim that re-opening procedures only post-
pone an inevitable amputation. It might be better to
amputate early, especially if the patient receives
a walking prosthesis. This may be true only for youn-
ger patients, since elderly patients if amputated, will
be constrained to a wheelchair and dependent on
nursing facilities.
Adjunctive antithrombotic medication is recom-
mended. Clopidogrel should be given to all patients
with aspirin intolerance due to the fact that antiplate-
let agents improve graft patency, especially in pros-
thetic grafts.17 Clopidogrel may also be useful in
addition to aspirin in cases with a marked tendency
for thrombosis. However, this has not been proven
in controlled trials. Warfarin has been reported toEur J Vasc Endovasc Surg Vol 32, December 2006improve patency of infrainguinal vein grafts, but not
prosthetic grafts.18
In conclusion, both thrombolysis and surgical
thrombectomy put a heavy strain on restricted re-
sources.19 The results of this study suggest that redo
procedures for occluded above-knee prosthetic grafts
are of limited value. Re-opening occluded above-
knee prosthetic bypasses implanted for critical ischae-
mia cannot be recommended except in cases of a
proven anastomotic lesion. Other cases needing re-
intervention should be treated by amputation or a
new arterial reconstruction.
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